Neurophysiological differences between patients clinically at high risk for schizophrenia and neurotypical controls – first steps in development of a biomarker

BACKGROUND: Schizophrenia is a severe, disabling and prevalent mental disorder without cure and with a variable, incomplete pharmacotherapeutic response. Prior to onset in adolescence or young adulthood a prodromal period of abnormal symptoms lasting weeks to years has been identified and operationa...

Descripción completa

Detalles Bibliográficos
Autores principales: Duffy, Frank H., D’Angelo, Eugene, Rotenberg, Alexander, Gonzalez-Heydrich, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630963/
https://www.ncbi.nlm.nih.gov/pubmed/26525736
http://dx.doi.org/10.1186/s12916-015-0516-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630963/
https://www.ncbi.nlm.nih.gov/pubmed/26525736
http://dx.doi.org/10.1186/s12916-015-0516-z

Ejemplares similares